['obesity']
['canagliflozin', 'phentermine', 'matching placebo to canagliflozin', 'matching placebo to phentermine']

        Inclusion Criteria:

          -  Must have BMI >=30 kg/m2 and <50 kg/m2 at screening or BMI >=27 kg/m2 and <50 kg/m2 at
             screening in the presence of a comorbidity of hypertension and/or dyslipidemia

          -  Must have stable weight, ie, change of < =5% in the 3 months before screening

          -  Must agree to utilize a highly effective method of birth control

        Exclusion Criteria:

          -  An established diagnosis of diabetes mellitus

          -  Has a history of obesity with a known secondary cause (eg, Cushing's disease/syndrome)

          -  Has a history of hereditary glucose-galactose malabsorption or primary renal
             glycosuria

          -  Myocardial infarction, unstable angina, revascularization procedure, or
             cerebrovascular accident within 12 weeks before screening

          -  Has an Glycated hemoglobin (HBA1c) greater than or equal (>=) to 65 percent

          -  An average of 3 seated blood pressure (BP) readings of systolic BP >= 160 mm Hg and/or
             Diastolic BP >= 100 millimeters of mercury at screening
      